About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2012 (2012), Article ID 798634, 8 pages
http://dx.doi.org/10.1155/2012/798634
Research Article

Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men

1Department of Urology, Stellenbosch University, P.O. Box 19063, Cape Town 7505, South Africa
2Department of Biostatistics and Epidemiology and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
3Department of Urology, Tygerberg Hospital, Cape Town 7505, South Africa
4University Cheikh Anta Diop and Hôpital Général de Grand Yoff, Dakar, Senegal

Received 25 May 2012; Revised 3 August 2012; Accepted 20 August 2012

Academic Editor: Camille Ragin

Copyright © 2012 Pedro Fernandez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Center, A. Jemal, J. Lortet-Tieulent et al., “International variation in prostate cancer incidence and mortality rates,” European Urology, vol. 61, no. 6, pp. 1079–1092, 2012. View at Publisher · View at Google Scholar
  4. N. B. Delongchamps, A. Singh, and G. P. Haas, “Epidemiology of prostate cancer in Africa: another step in the understanding of the disease?” Current Problems in Cancer, vol. 31, no. 3, pp. 226–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Platz and E. Giovannucci, “Prostate cancer,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. F. Fraumeni, Eds., pp. 1128–1150, Oxford University Press, New York, NY, USA, 2006.
  6. F. T. Odedina, T. O. Akinremi, F. Chinegwundoh et al., “Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa,” Infectious Agents and Cancer, vol. 4, supplement 1, article S2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Parkin, F. Sitas, M. Chirenje, L. Stein, R. Abratt, and H. Wabinga, “Part I: cancer in indigenous Africans-burden, distribution, and trends,” The Lancet Oncology, vol. 9, no. 7, pp. 683–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Jemal, F. Bray, D. Forman et al., “Cancer burden in Africa and opportunities for prevention,” Cancer, vol. 118, no. 18, pp. 4372–4384, 2012. View at Publisher · View at Google Scholar
  9. E. de Wit, W. Delport, C. E. Rugamika et al., “Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape,” Human Genetics, vol. 128, no. 2, pp. 145–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Mqoqi, P. Kellett, F. Sitas, and M. Jula, “Incidence of histologically diagnosed cancer in South Africa, 1998-1999,” in National Cancer Registry Johannesburg, National Cancer Registry of South Africa, 2004.
  11. C. F. Heyns, S. Mathee, A. Isaacs, A. Kharwa, P. M. de Beer, and M. A. Pretorius, “Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa,” BJU International, vol. 91, no. 9, pp. 785–788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. F. Heyns, M. Fisher, A. Lecuona, and A. van der Merwe, “Prostate cancer among different racial groups in the western cape: presenting features and management,” South African Medical Journal, vol. 101, no. 4, pp. 267–270, 2011. View at Scopus
  13. S. M. Gueye, C. M. Zeigler-Johnson, T. Friebel et al., “Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men,” Urology, vol. 61, no. 5, pp. 987–992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Zeigler-Johnson, H. Rennert, R. D. Mittal et al., “Evaluation of prostate cancer characteristics in four populations worldwide,” The Canadian Journal of Urology, vol. 15, no. 3, pp. 4056–4064, 2008. View at Scopus
  15. L. Niang, C. N. Kouka, M. Jalloh, and S. M. Gueye, “Screening for prostate cancer by digital rectal examination and PSA determination in Senegal,” ISRN Oncology, vol. 2011, Article ID 943704, 4 pages, 2011. View at Publisher · View at Google Scholar
  16. M. C. Parkinson, “Pre-neoplastic lesions of the prostate,” Histopathology, vol. 27, no. 4, pp. 301–311, 1995. View at Scopus
  17. R. A. Kittles, W. Chen, R. K. Panguluri et al., “CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?” Human Genetics, vol. 110, no. 6, pp. 553–560, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Plummer, D. V. Conti, P. L. Paris, A. P. Curran, G. Casey, and J. S. Witte, “CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 9, pp. 928–932, 2003. View at Scopus
  19. C. Zeigler-Johnson, T. Friebel, A. H. Walker et al., “CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer,” Cancer Research, vol. 64, no. 22, pp. 8461–8467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Stone, L. D. Ratnasinghe, G. L. Emerson et al., “CYP3A43 Pro340 Ala polymorphism and prostate cancer risk in African Americans and Caucasians,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1257–1261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. T. R. Rebbeck, H. Rennert, A. H. Walker et al., “Joint effects of inflammation and androgen metabolism on prostate cancer severity,” International Journal of Cancer, vol. 123, no. 6, pp. 1385–1389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Jaffe, S. B. Malkowicz, A. H. Walker et al., “Association of SRD5A2 genotype and pathological characteristics of prostate tumors,” Cancer Research, vol. 60, no. 6, pp. 1626–1630, 2000. View at Scopus
  23. M. S. Cicek, D. V. Conti, A. Curran et al., “Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR,” Prostate, vol. 59, no. 1, pp. 69–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. V. M. Hayes, G. Severi, E. J. D. Padilla et al., “5α-reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia,” International Journal of Cancer, vol. 120, no. 4, pp. 776–780, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Neslund-Dudas, C. H. Bock, K. Monaghan et al., “SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness,” Prostate, vol. 67, no. 15, pp. 1654–1663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Paz-y-Miño, T. Witte, P. Robles, W. Llumipanta, M. Díaz, and M. Arévalo, “Association among polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population,” Cancer Genetics and Cytogenetics, vol. 189, no. 2, pp. 71–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Fernandez, P. D. de Beer, L. D. van der Merwe, and C. F. Heyns, “Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men,” South African Medical Journal, vol. 100, no. 11, pp. 741–745, 2010. View at Scopus
  28. C. M. Zeigler-Johnson, A. H. Walker, B. Mancke et al., “Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4,” Human Heredity, vol. 54, no. 1, pp. 13–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Fernandez, P. M. de Beer, L. van der Merwe, and C. F. Heyns, “COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men,” Carcinogenesis, vol. 29, no. 12, pp. 2347–2350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. L. Freedman, D. Reich, K. L. Penney et al., “Assessing the impact of population stratification on genetic association studies,” Nature Genetics, vol. 36, no. 4, pp. 388–393, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. B. Spurdle, B. Goodwin, E. Hodgson et al., “The CYP3A4* 1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer,” Pharmacogenetics, vol. 12, no. 5, pp. 355–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. N. M. Makridakis, R. K. Ross, M. C. Pike et al., “Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA,” The Lancet, vol. 354, no. 9183, pp. 975–978, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Makridakis, R. K. Ross, M. C. Pike et al., “A prevalent missense substitution that modulates activity of prostatic steroid 5α-reductase,” Cancer Research, vol. 57, no. 6, pp. 1020–1022, 1997. View at Scopus
  34. V. Petrow, “The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications,” Prostate, vol. 9, no. 4, pp. 343–361, 1986. View at Scopus
  35. K. Stefflova, M. C. Dulik, A. A. Pai et al., “Evaluation of group genetic ancestry of populations from Philadelphia and Dakar in the context of sex-biased admixture in the Americas,” PLoS ONE, vol. 4, no. 11, Article ID e7842, 2009. View at Publisher · View at Google Scholar · View at Scopus